English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
e
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Login
Videos
[2280]
News
[5215]
Articles
[128]
Editorials
[4]
Conferences
[157]
e
learning
[13]
Research:
ALK-positive advanced non-small cell lung cancer patients with poor performance status: Outcomes in a real-world scenario
Ajaykumar Singh,
Akhil Kapoor,
Vanita Noronha,
Vijay Patil,
Nandini Menon,
Abhishek Mahajan,
Amit Janu,
Nilendu Purandare,
Rajiv Kaushal,
Kumar Prabhash
7 Jun 2022
https://doi.org/10.3332/ecancer.2022.1407
Abstract
|
Full Article
|
PDF
Case Report:
Fumarate hydratase-deficient renal cell carcinoma in extended remission with bevacizumab and erlotinib
Shubham Tomar,
Lakhan Kashyap,
Akhil Kapoor
30 May 2022
https://doi.org/10.3332/ecancer.2022.1404
Abstract
|
Full Article
|
PDF
Research:
Treatment pattern and outcomes in de novo T790M-mutated non-small cell lung cancer
Goutam Santosh Panda,
Vanita Noronha,
Darshit Shah,
George John,
Anuradha Chougule,
Vijay Patil,
Rajiv Kumar,
Nandini Menon,
Ajay Singh,
Pratik Chandrani,
Abhishek Mahajan,
Kumar Prabhash
6 May 2022
https://doi.org/10.3332/ecancer.2022.1385
Abstract
|
Full Article
|
PDF
Research:
The concordance between IHC and ISH for HER-2 testing in breast cancer in Nakhon Pathom Hospital, Thailand, based on the ASCO/CAP 2018 guidelines: a retrospective study
Tawasapon Thambamroong
31 Mar 2022
https://doi.org/10.3332/ecancer.2022.1370
Abstract
|
Full Article
|
PDF
Clinical Study:
METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours
João Glasberg,
Aley Talans,
Thomás Rivelli Giolo,
Débora Zachello Recchimuzzi,
João Evangelista Bezerra Neto,
Rossana Veronica Mendonza Lopez,
Paulo Marcelo Gehm Hoff,
Rachel P Riechelmann
31 Mar 2022
https://doi.org/10.3332/ecancer.2022.1369
Abstract
|
Full Article
|
PDF
Research:
The benefits of trastuzumab in the treatment of HER2+ breast cancer as a function of exposure time
Felipe Andrés Cordero da Luz,
Eduarda da Costa Marinho,
Camila Piqui Nascimento,
Lara de Andrade Marques,
Patrícia Ferreira Ribeiro Delfino,
Rafael Mathias Antonioli,
Marcelo José Barbosa Silva,
Rogério Agenor de Araújo
20 Jan 2022
https://doi.org/10.3332/ecancer.2022.1347
Abstract
|
Full Article
|
PDF
Clinical Study:
Predictors of pathologic complete response to neoadjuvant treatment in HER2-overexpressing breast cancer: a retrospective analysis using real-world data
Isabel Saffie Vega,
Jorge Sapunar Zenteno,
Felipe Buscaglia Fernandez,
Felipe Reyes Cosmelli,
Rodrigo Lagos Chavez,
Badir Chahuán Manzur
6 Jan 2022
https://doi.org/10.3332/ecancer.2022.1338
Abstract
|
Full Article
|
PDF
Research:
Implementation of a molecular tumour board in LATAM: the impact on treatment decisions for patients evaluated at Instituto Alexander Fleming, Argentina
Martín Osvaldo Angel,
Carmen Pupareli,
Tomas Soule,
Florencia Tsou,
Mariano Leiva,
Federico Losco,
Federico Esteso,
Juan Manuel O'Connor,
Romina Luca,
Fernando Petracci,
Romina Girotti,
Yamil Damián Mahmoud,
Claudio Martín,
Matías Chacón
1 Nov 2021
https://doi.org/10.3332/ecancer.2021.1312
Abstract
|
Full Article
|
PDF
Erratum:
Near-complete response to low-dose ceritinib in recurrent infantile inflammatory myofibroblastic tumour
Abhenil Mittal,
Aarushi Gupta,
Sameer Rastogi,
Adarsh Barwad,
Swati Sharma
13 Sep 2021
https://doi.org/10.3332/ecancer.2021.1286
Abstract
|
Full Article
|
PDF
Research:
Pazopanib in rare histologies of metastatic soft tissue sarcoma
Babita Kataria,
Aparna Sharma,
Bivas Biswas,
Sameer Bakhshi,
Deepam Pushpam
2 Sep 2021
https://doi.org/10.3332/ecancer.2021.1281
Abstract
|
Full Article
|
PDF
<
1
2
3
4
5
6
7
...
13
>
More from
e
cancer